You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are 4 stocks added to the Zacks Rank #1 (Strong Buy) List for today:
Vertex Pharmaceuticals Incorporated (VRTX - Free Report) : This company that engages in developing and commercializing therapies for treating cystic fibrosis has witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.8% over the last 60 days.
Vertex Pharmaceuticals Incorporated Price and Consensus
Gaming and Leisure Properties, Inc. (GLPI - Free Report) : This company that is engaged in the business of acquiring, financing, and owning real estate property has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.8% over the last 60 days.
Gaming and Leisure Properties, Inc. Price and Consensus
The Charles Schwab Corporation (SCHW - Free Report) : This company that provides wealth management, securities brokerage, banking, asset management, custody, and financial advisory services has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.4% over the last 60 days.
The Charles Schwab Corporation Price and Consensus
Zynerba Pharmaceuticals, Inc. : This clinical stage specialty pharmaceutical company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 18.7% over the last 60 days.
Would you like to see the updated picks from our best market-beating strategies? From 2017 through Q3 2019, while the S&P 500 gained +39.6%, five of our strategies returned +51.8%, +57.5%, +96.9%, +119.0%, and even +158.9%.
This outperformance has not just been a recent phenomenon. From 2000 – Q3 2019, while the S&P averaged +5.6% per year, our top strategies averaged up to +54.1% per year.
Here are 4 stocks added to the Zacks Rank #1 (Strong Buy) List for today:
Vertex Pharmaceuticals Incorporated (VRTX - Free Report) : This company that engages in developing and commercializing therapies for treating cystic fibrosis has witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.8% over the last 60 days.
Vertex Pharmaceuticals Incorporated Price and Consensus
Vertex Pharmaceuticals Incorporated price-consensus-chart | Vertex Pharmaceuticals Incorporated Quote
Gaming and Leisure Properties, Inc. (GLPI - Free Report) : This company that is engaged in the business of acquiring, financing, and owning real estate property has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.8% over the last 60 days.
Gaming and Leisure Properties, Inc. Price and Consensus
Gaming and Leisure Properties, Inc. price-consensus-chart | Gaming and Leisure Properties, Inc. Quote
The Charles Schwab Corporation (SCHW - Free Report) : This company that provides wealth management, securities brokerage, banking, asset management, custody, and financial advisory services has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.4% over the last 60 days.
The Charles Schwab Corporation Price and Consensus
The Charles Schwab Corporation price-consensus-chart | The Charles Schwab Corporation Quote
Zynerba Pharmaceuticals, Inc. : This clinical stage specialty pharmaceutical company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 18.7% over the last 60 days.
Zynerba Pharmaceuticals, Inc. Price and Consensus
Zynerba Pharmaceuticals, Inc. price-consensus-chart | Zynerba Pharmaceuticals, Inc. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here
Today's Best Stocks from Zacks
Would you like to see the updated picks from our best market-beating strategies? From 2017 through Q3 2019, while the S&P 500 gained +39.6%, five of our strategies returned +51.8%, +57.5%, +96.9%, +119.0%, and even +158.9%.
This outperformance has not just been a recent phenomenon. From 2000 – Q3 2019, while the S&P averaged +5.6% per year, our top strategies averaged up to +54.1% per year.
See their latest picks free >>